Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-07-16
1999-10-19
Celsa, Bennett
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 14, 514 16, 514 15, 4241851, 4241931, 530300, 530328, 530327, 530806, A01N 3718
Patent
active
059688980
ABSTRACT:
An immunomodulatory peptide is disclosed which is a thymic humoral factor .gamma.2 (THF-.gamma.2) analog of at least eight amino acids or a functional derivative or a salt thereof. The peptide has the amino acid sequence: Leu-Glu-Asp-Gly-Pro-Lys-Phe-Leu (SEQ ID No:1) but differing therefrom by
REFERENCES:
patent: 4621135 (1986-11-01), Trainin et al.
Barak et al., "Thymic humoral factor-.gamma.2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth" Exp. Hematol., 20:173-177 (1992).
Ben-Hur et al., "Immune modulation exerted by thymic humoral factor THF-.gamma.2 on T cell subsets and IL-2 production . . . " Immunopharmac and Immunotoxico, 12(1):(123-133 (1990).
Burstein et al., "Thymic humoral factor .gamma.2: purification and amino acid sequence of an immunoregulatory peptide . . . " Biochemistry, 27:4066-4071 (1988).
Goso et al., "Effect of synthetic thymic humoral factor (THF-.gamma.2) on T cell activities in immunodeficient ageing mice" Clin. Exp. Immunol., 87:346-351 (1992).
Katorza et al., "Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus . . . " Clin. Exp. Immunol., 70:268-275 (1987).
Ophir et al., "THF-.gamma.2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil treated mice . . . " Cancer Immunol and Immunother, 30:119-125 (1989).
Ophir et al., "A synthetic thymic hormone, THF-.gamma.2, repairs immuno- of mice cured from plasmacytoma by Melphalan" Int. J. Cancer, 45:1190-1194, (1990).
Ophir et al., "THF-.gamma.2, a synthetic thymic hormone, increases effectiveness of combined chemotherapy and immunotherapy . . . " Int. J. Immunopharmac., 12:751-754 (1990).
Ophir et al., "Therapeutic effectiveness against MOPC-315 plasmacytoma of low or high doses of the synthetic thymic . . . " Int. J. Cancer, 48:96-100 (1991).
Pecht et al., "The thymic hormone THF-.gamma.2 selectively enhances secretion of IL-2 but not IL-6 by spleen and bone marrow cells" 8th Int'l Congress of Immunology, Budapest, Abstract (1992).
Pecht et al., "Potentiation of myeloid colony-formation in bone marrow of intact and neonatally thymectomized mice . . . " Exp. Hematol., 21:277-282 (1993).
Rager-Zisman et al., "Therapy of a fatal murine cylomegalovirus infection with thymic humoral factor . . . " Clin. Exp. Immunol., 79:246-252 (1990).
Trainin et al., "Biological and clinical properties of THF" Thymus, 6:137-150 (1985).
Trainin et al., "The use of THF, a thymic hormone . . . " In: Novel Approaches in Cancer Therapy, Lapis & Eckhardt (eds) Karger (Basel)/Akademiai Kiado (Budapest), vol. 5, 253-260 (1987).
deCastiglione, "Solution synthesis of an octapeptide" EP, A, 0311392 (Apr. 12, 1989).
Indig et al., Hydrolysis of thymic humoral factor .gamma.2 by neutral endopeptidase (EC 3.4.24.11) Biochem. J. 278:891-894 (1991).
Handzel et al., "Immunomodulation of T cell deficiency in humans by thymic humoral factor . . . " J. Biol. Res. Mod., 9:269-278 (1990).
Dje, M.K., et al., Three genes under different developmental control encode elongation factor 1-alpha in Xenopus laevis, Nucleic Acids Research, 18(12):3489-3493, 1990.
Forino, R., et al., Side reactions in the large-scale pharmaceutical production of THF-gamma2 by solution synthesis, Peptides, 22:257-258, 1992.
Sundstrom, P., et al., Sequence analysis of the EF-1alpha gene family of Mucor racemosus, Nucleic Acids Research, 15(23):9997-10005, 1987.
Wiederrecht, G., et al., FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins, Proc. Natl. Acad. Sci. USA, 88:1029-1033, 1991.
Burstein Yigal
Trainin Nathan
Celsa Bennett
Yeda Research and Developement Co. Ltd.
LandOfFree
THF-.gamma.2 analogs and pharmaceutical compositions comprising does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with THF-.gamma.2 analogs and pharmaceutical compositions comprising , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and THF-.gamma.2 analogs and pharmaceutical compositions comprising will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055414